Decreased CPS1-IT1 expression was associated with shorter metastasis-free and overall survival after surgery in HCC patients, supporting the hypothesis that CPS1-IT1 can serve as a molecular prognostic factor that can be used to identify high-risk patients for further intense treatment. Here, CPS1 is linked to hepatocellular carcinoma.